S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

LNTH Lantheus Holdings Inc

92.07

-1.18 (-1.27%)

After Hours

Last Updated: 15:55:22

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/14/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

03/01/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Margaret Campbell, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Paul Blanchfield

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Lantheus (NASDAQ:LNTH)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Lantheus Charts.

Lantheus (NASDAQ:LNTH)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Lantheus Charts.

Lantheus Holdings Inc News

Form 8-K - Current report
Monday 23 December 2024 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 19 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 20 November 2024 (1 month ago) • Edgar (US Regulatory)

Lantheus Announces Share Repurchase Program
Wednesday 20 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 19 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 18 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Lantheus to Present at the Jefferies London Healthcare Conference
Wednesday 13 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025
Monday 11 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

More Lantheus Holdings Inc News Articles

Good Vibrations Shoes (PK)

KULR Technology

Virexit Technologies (PK)

North Bay Resources (PK)

Bioelectronics (PK)

Code Green Apparel (PK)

Northwest Biotherapeutics (QB)

Hallmark Venture (PK)

Rennova Health (CE)

Intergrated Cannabis Sol... (PK)

Elite Pharmaceuticals (QB)

Fannie Mae (QB)

Movement Industries (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions